Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Melanoma 20Carcinoma, Renal Cell 11Prostatic Neoplasms 8Uveal Melanoma 7Carcinoma, Non-Small-Cell Lung 7Neoplasm Metastasis 5Myelodysplastic Syndromes 5Clear-cell metastatic renal cell carcinoma 5Triple Negative Breast Neoplasms 4Lung Neoplasms 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Brain Neoplasms 4Pancreatic Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Hematologic Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2

Interventions

Ipilimumab 6tremelimumab 5durvalumab 5Nivolumab 3Capecitabine 3Radiotherapy 2Radiation 2Paclitaxel 2CTLA-4 Antigen 2Blood Specimen Collection 2relatlimab 1poly ICLC 1lenvatinib 1folfirinox 1balstilimab 1Vaccines 1Vaccination 1Surgical Procedures, Operative 1Radiosurgery 1Platinum 1Peptides 1Pemetrexed 1Oxaliplatin 1Opdualag 1Monophenol Monooxygenase 1Melphalan 1Leucovorin 1Immunotherapy 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Insulin-Dependent, 12 × CTLA-4 Antigen × Clear all
NCT03182816 2017-06-09

CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor

Shanghai Cell Therapy Research Institute

Phase 1/2 Unknown
40 enrolled

Diabetes Mellitus, Insulin-Dependent, 12

NCT03179007 2017-06-07

CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor

Shanghai Cell Therapy Research Institute

Phase 1/2 Unknown
40 enrolled

Diabetes Mellitus, Insulin-Dependent, 12

Data powered by HemOnc (CC BY 4.0) Colophon âš¡